Full-Time

Sr. Staff Scientist

Formulations & Polymers, R&D

Posted on 4/16/2025

Stryker

Stryker

10,001+ employees

Develops and manufactures medical devices and equipment

Compensation Overview

$100.5k - $215.3k/yr

+ Bonus

Senior, Expert

Company Historically Provides H1B Sponsorship

Fremont, CA, USA

Category
Lab & Research
Life Sciences
Physical Sciences
Requirements
  • Bachelor's degree in Polymer Chemistry, Chemistry, Polymer Science, Materials Science or applicable technical field.
  • Minimum 6+ years’ experience in the development of polymer formulations.
  • Proficiency in chemical synthesis, mechanical and biocompatibility testing, rheology, and standard polymer characterization methods, including GPC, NMR, DMA, FTIR, and optical spectroscopy.
  • Experience in drug elution studies.
  • Knowledge of Design of Experiments (DOE), formulation development, process scale-up, technology transfer, and collaboration with internal and external stakeholders.
Responsibilities
  • Develop novel polymer formulations and additives for implantable embolization devices and material applications.
  • Perform polymer and monomer synthesis, characterizing essential physical and chemical features for optimal material performance.
  • Conduct experimental studies to analyze chemical and physical degradation pathways of polymeric biomaterials.
  • Identify high-risk areas within formulation chemistry, ensuring thorough vetting through experimentation and targeted studies.
  • Optimize and scale up formulations to manufacturable processes, characterizing solubility, loading capacity, radiopacity, reaction rates, degradation profiles, biocompatibility, and drug/solvent release mechanisms.
  • Design and execute pre-formulation and process development, ensuring robust, scalable formulation strategies and smooth technology transfer.
  • Collaborate cross-functionally with process development, quality, manufacturing, regulatory, clinical, and marketing teams to drive project success.
  • Ensure compliance with quality standards, support process optimization, and guide technicians and entry-level scientists.
Desired Qualifications
  • Master's degree or Ph.D. in Polymer Chemistry, Chemistry, Polymer Science, Materials Science, or applicable technical field.

Stryker develops and manufactures medical devices and equipment aimed at improving patient care and surgical efficiency. Their products include surgical tools, neurotechnology devices, and orthopedic implants, which are sold directly to hospitals and clinics worldwide. Stryker stands out from competitors by focusing on high-quality products and a commitment to advancing healthcare solutions. The company's goal is to enhance the overall healthcare experience for both patients and medical professionals.

Company Size

10,001+

Company Stage

IPO

Headquarters

Kalamazoo, Michigan

Founded

1941

Simplify Jobs

Simplify's Take

What believers are saying

  • Growing demand for minimally invasive solutions aligns with Stryker's strategic acquisitions.
  • The orthopedic implants market growth benefits Stryker's expanding product line.
  • Stryker's acquisition of Inari Medical positions it in a high-growth vascular market.

What critics are saying

  • Integration challenges from acquisitions may strain Stryker's resources.
  • Rapid tech advancements risk obsolescence of Stryker's current products.
  • Regulatory scrutiny on acquisitions could delay Stryker's market entry.

What makes Stryker unique

  • Stryker's acquisitions enhance its minimally invasive surgical solutions portfolio.
  • Entry into the peripheral vascular segment diversifies Stryker's market presence.
  • Stryker's focus on AI integration boosts diagnostic accuracy and operational efficiency.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Medical & prescription plans

Supplemental health benefits

Flexible Spending accounts

Employee Assistance Program

Short-term & long-term disability

Tuition reimbursement

401(k) plan

Employee Stock Purchase Plan

Company News

GlobeNewswire
Jan 6th, 2025
Stryker announces definitive agreement to acquire Inari Medical, Inc., providing entry into high-growth peripheral vascular segment

Portage, Michigan and Irvine, California, Jan. 06, 2025 (GLOBE NEWSWIRE) --  Stryker (NYSE: SYK), a global leader in medical technologies, announced...

PR Newswire
Sep 20th, 2024
Stryker completes acquisition of NICO Corporation, expanding minimally invasive solutions for brain tumor removal and stroke care

/PRNewswire/ -- Stryker (NYSE: SYK), a global leader in medical technologies, announced today that it has completed the acquisition of NICO Corporation, a...

Surgical Robotics Technology
Aug 22nd, 2024
Stryker Announces Definitive Agreement to Acquire Vertos Medical Inc.

Stryker has announced a definitive agreement to acquire Vertos Medical, a privately held company providing a minimally invasive solution.

Surgical Robotics Technology
Aug 12th, 2024
Stryker Announces Definitive Agreement to Acquire care.ai

Stryker has announced a definitive agreement to acquire care.ai.

PR Newswire
Jul 31st, 2024
Stryker Acquires MOLLI Surgical Inc.

Stryker (NYSE:SYK) has completed the acquisition of MOLLI Surgical Inc., a company specializing in wire-free soft tissue localization technology for breast conserving surgery. The MOLLI 2 localization system enhances surgical workflow with its small 3.2 mm marker and real-time feedback. This acquisition strengthens Stryker's breast cancer care portfolio, complementing its existing SPY fluorescence imaging technology. For more information, visit www.stryker.com.